![](https://bl-i.thgim.com/public/incoming/du4u7g/article68418195.ece/alternates/LANDSCAPE_1200/IMG_iStock-1314471030_2_1_36A6T7N8.jpg)
Dr Reddy’s signs non-exclusive patent licensing agreement with Takeda to commercialise gastrointestinal drug in India
Dr Reddy’s Laboratories Ltd announced on Thursday that it has entered into a non-exclusive patent licensing agreement with Japan’s Takeda Pharmaceutical Company Ltd (Takeda) to commercialise Vonoprazan tablets in India. Vonoprazan is a novel, orally active …